Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065117
Status:
TERMINATED
Last Update Posted:
2011-01-26
First Post:
2003-07-17
Brief Title:
Safety Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the Safety Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 6126IL00007 | None | None | None |